 | • レポートコード：MRC2-11QY11552 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は嚢胞様黄斑浮腫のグローバル市場について調査・分析したレポートです。種類別（非ステロイド性抗炎症薬、抗血管内皮増殖因子（VEGF）剤、炭酸脱水酵素阻害剤、ステロイド）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別嚢胞様黄斑浮腫の競争状況、市場シェア ・世界の嚢胞様黄斑浮腫市場：種類別市場規模 2015年-2020年（非ステロイド性抗炎症薬、抗血管内皮増殖因子（VEGF）剤、炭酸脱水酵素阻害剤、ステロイド） ・世界の嚢胞様黄斑浮腫市場：種類別市場規模予測 2021年-2026年（非ステロイド性抗炎症薬、抗血管内皮増殖因子（VEGF）剤、炭酸脱水酵素阻害剤、ステロイド） ・世界の嚢胞様黄斑浮腫市場：用途別市場規模 2015年-2020年（病院、外来手術センター、その他） ・世界の嚢胞様黄斑浮腫市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、その他） ・北米の嚢胞様黄斑浮腫市場分析：米国、カナダ ・ヨーロッパの嚢胞様黄斑浮腫市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの嚢胞様黄斑浮腫市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の嚢胞様黄斑浮腫市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの嚢胞様黄斑浮腫市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：EMMES、Fovea Pharmaceuticals、Icon Bioscience、Merck、Sanwa Kagaku Kenkyusho、Novartis、Johns Hopkins University、Wake Forest University、Iladevi Cataract、IOL Research Center、Rabin Medical Center、Kyushu University、Wills Eye Institute ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disruption of the normal blood-retinal barrier which leads to leakage from the perifoveal retinal capillaries causing accumulation of fluid within the intracellular spaces of the retina, mainly in the outer plexiform layer. CME is of two types: pseudophakic and nonpseudophakic cystoid macular edema. Pseudophakic cystoids macular edema is when the cause of occurrence is known while nonpseudophakic is the condition where no specific clinical findings have been observed. Symptoms of cystoids macular edema are blurred or decreased central vision.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.
Market Analysis and Insights: Global Cystoid Macular Edema Market
The global Cystoid Macular Edema market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cystoid Macular Edema Scope and Market Size
Cystoid Macular Edema market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cystoid Macular Edema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
EMMES
Fovea Pharmaceuticals
Icon Bioscience
Merck
Sanwa Kagaku Kenkyusho
Novartis
Johns Hopkins University
Wake Forest University
Iladevi Cataract
IOL Research Center
Rabin Medical Center
Kyushu University
Wills Eye Institute
Market segment by Type, the product can be split into
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Steroids
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cystoid Macular Edema Revenue
1.4 Market by Type
1.4.1 Global Cystoid Macular Edema Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non Steroidal Anti-Inflammatory Drugs
1.4.3 Anti- Vascular Endothelial Growth Factor (VEGF) Agents
1.4.4 Carbonic Anhydrase Inhibitors
1.4.5 Steroids
1.5 Market by Application
1.5.1 Global Cystoid Macular Edema Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cystoid Macular Edema Market Perspective (2015-2026)
2.2 Global Cystoid Macular Edema Growth Trends by Regions
2.2.1 Cystoid Macular Edema Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cystoid Macular Edema Historic Market Share by Regions (2015-2020)
2.2.3 Cystoid Macular Edema Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cystoid Macular Edema Market Growth Strategy
2.3.6 Primary Interviews with Key Cystoid Macular Edema Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cystoid Macular Edema Players by Market Size
3.1.1 Global Top Cystoid Macular Edema Players by Revenue (2015-2020)
3.1.2 Global Cystoid Macular Edema Revenue Market Share by Players (2015-2020)
3.1.3 Global Cystoid Macular Edema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cystoid Macular Edema Market Concentration Ratio
3.2.1 Global Cystoid Macular Edema Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cystoid Macular Edema Revenue in 2019
3.3 Cystoid Macular Edema Key Players Head office and Area Served
3.4 Key Players Cystoid Macular Edema Product Solution and Service
3.5 Date of Enter into Cystoid Macular Edema Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cystoid Macular Edema Historic Market Size by Type (2015-2020)
4.2 Global Cystoid Macular Edema Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cystoid Macular Edema Market Size by Application (2015-2020)
5.2 Global Cystoid Macular Edema Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cystoid Macular Edema Market Size (2015-2020)
6.2 Cystoid Macular Edema Key Players in North America (2019-2020)
6.3 North America Cystoid Macular Edema Market Size by Type (2015-2020)
6.4 North America Cystoid Macular Edema Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cystoid Macular Edema Market Size (2015-2020)
7.2 Cystoid Macular Edema Key Players in Europe (2019-2020)
7.3 Europe Cystoid Macular Edema Market Size by Type (2015-2020)
7.4 Europe Cystoid Macular Edema Market Size by Application (2015-2020)
8 China
8.1 China Cystoid Macular Edema Market Size (2015-2020)
8.2 Cystoid Macular Edema Key Players in China (2019-2020)
8.3 China Cystoid Macular Edema Market Size by Type (2015-2020)
8.4 China Cystoid Macular Edema Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cystoid Macular Edema Market Size (2015-2020)
9.2 Cystoid Macular Edema Key Players in Japan (2019-2020)
9.3 Japan Cystoid Macular Edema Market Size by Type (2015-2020)
9.4 Japan Cystoid Macular Edema Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cystoid Macular Edema Market Size (2015-2020)
10.2 Cystoid Macular Edema Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cystoid Macular Edema Market Size by Type (2015-2020)
10.4 Southeast Asia Cystoid Macular Edema Market Size by Application (2015-2020)
11 India
11.1 India Cystoid Macular Edema Market Size (2015-2020)
11.2 Cystoid Macular Edema Key Players in India (2019-2020)
11.3 India Cystoid Macular Edema Market Size by Type (2015-2020)
11.4 India Cystoid Macular Edema Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cystoid Macular Edema Market Size (2015-2020)
12.2 Cystoid Macular Edema Key Players in Central & South America (2019-2020)
12.3 Central & South America Cystoid Macular Edema Market Size by Type (2015-2020)
12.4 Central & South America Cystoid Macular Edema Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 EMMES
13.1.1 EMMES Company Details
13.1.2 EMMES Business Overview
13.1.3 EMMES Cystoid Macular Edema Introduction
13.1.4 EMMES Revenue in Cystoid Macular Edema Business (2015-2020))
13.1.5 EMMES Recent Development
13.2 Fovea Pharmaceuticals
13.2.1 Fovea Pharmaceuticals Company Details
13.2.2 Fovea Pharmaceuticals Business Overview
13.2.3 Fovea Pharmaceuticals Cystoid Macular Edema Introduction
13.2.4 Fovea Pharmaceuticals Revenue in Cystoid Macular Edema Business (2015-2020)
13.2.5 Fovea Pharmaceuticals Recent Development
13.3 Icon Bioscience
13.3.1 Icon Bioscience Company Details
13.3.2 Icon Bioscience Business Overview
13.3.3 Icon Bioscience Cystoid Macular Edema Introduction
13.3.4 Icon Bioscience Revenue in Cystoid Macular Edema Business (2015-2020)
13.3.5 Icon Bioscience Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Cystoid Macular Edema Introduction
13.4.4 Merck Revenue in Cystoid Macular Edema Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Sanwa Kagaku Kenkyusho
13.5.1 Sanwa Kagaku Kenkyusho Company Details
13.5.2 Sanwa Kagaku Kenkyusho Business Overview
13.5.3 Sanwa Kagaku Kenkyusho Cystoid Macular Edema Introduction
13.5.4 Sanwa Kagaku Kenkyusho Revenue in Cystoid Macular Edema Business (2015-2020)
13.5.5 Sanwa Kagaku Kenkyusho Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Cystoid Macular Edema Introduction
13.6.4 Novartis Revenue in Cystoid Macular Edema Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Johns Hopkins University
13.7.1 Johns Hopkins University Company Details
13.7.2 Johns Hopkins University Business Overview
13.7.3 Johns Hopkins University Cystoid Macular Edema Introduction
13.7.4 Johns Hopkins University Revenue in Cystoid Macular Edema Business (2015-2020)
13.7.5 Johns Hopkins University Recent Development
13.8 Wake Forest University
13.8.1 Wake Forest University Company Details
13.8.2 Wake Forest University Business Overview
13.8.3 Wake Forest University Cystoid Macular Edema Introduction
13.8.4 Wake Forest University Revenue in Cystoid Macular Edema Business (2015-2020)
13.8.5 Wake Forest University Recent Development
13.9 Iladevi Cataract
13.9.1 Iladevi Cataract Company Details
13.9.2 Iladevi Cataract Business Overview
13.9.3 Iladevi Cataract Cystoid Macular Edema Introduction
13.9.4 Iladevi Cataract Revenue in Cystoid Macular Edema Business (2015-2020)
13.9.5 Iladevi Cataract Recent Development
13.10 IOL Research Center
13.10.1 IOL Research Center Company Details
13.10.2 IOL Research Center Business Overview
13.10.3 IOL Research Center Cystoid Macular Edema Introduction
13.10.4 IOL Research Center Revenue in Cystoid Macular Edema Business (2015-2020)
13.10.5 IOL Research Center Recent Development
13.11 Rabin Medical Center
10.11.1 Rabin Medical Center Company Details
10.11.2 Rabin Medical Center Business Overview
10.11.3 Rabin Medical Center Cystoid Macular Edema Introduction
10.11.4 Rabin Medical Center Revenue in Cystoid Macular Edema Business (2015-2020)
10.11.5 Rabin Medical Center Recent Development
13.12 Kyushu University
10.12.1 Kyushu University Company Details
10.12.2 Kyushu University Business Overview
10.12.3 Kyushu University Cystoid Macular Edema Introduction
10.12.4 Kyushu University Revenue in Cystoid Macular Edema Business (2015-2020)
10.12.5 Kyushu University Recent Development
13.13 Wills Eye Institute
10.13.1 Wills Eye Institute Company Details
10.13.2 Wills Eye Institute Business Overview
10.13.3 Wills Eye Institute Cystoid Macular Edema Introduction
10.13.4 Wills Eye Institute Revenue in Cystoid Macular Edema Business (2015-2020)
10.13.5 Wills Eye Institute Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cystoid Macular Edema Key Market Segments
Table 2. Key Players Covered: Ranking by Cystoid Macular Edema Revenue
Table 3. Ranking of Global Top Cystoid Macular Edema Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cystoid Macular Edema Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non Steroidal Anti-Inflammatory Drugs
Table 6. Key Players of Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Table 7. Key Players of Carbonic Anhydrase Inhibitors
Table 8. Key Players of Steroids
Table 9. Global Cystoid Macular Edema Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cystoid Macular Edema Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cystoid Macular Edema Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cystoid Macular Edema Market Share by Regions (2015-2020)
Table 13. Global Cystoid Macular Edema Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cystoid Macular Edema Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cystoid Macular Edema Market Growth Strategy
Table 19. Main Points Interviewed from Key Cystoid Macular Edema Players
Table 20. Global Cystoid Macular Edema Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cystoid Macular Edema Market Share by Players (2015-2020)
Table 22. Global Top Cystoid Macular Edema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystoid Macular Edema as of 2019)
Table 23. Global Cystoid Macular Edema by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cystoid Macular Edema Product Solution and Service
Table 26. Date of Enter into Cystoid Macular Edema Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cystoid Macular Edema Market Size Share by Type (2015-2020)
Table 30. Global Cystoid Macular Edema Revenue Market Share by Type (2021-2026)
Table 31. Global Cystoid Macular Edema Market Size Share by Application (2015-2020)
Table 32. Global Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cystoid Macular Edema Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cystoid Macular Edema Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cystoid Macular Edema Market Share (2019-2020)
Table 36. North America Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cystoid Macular Edema Market Share by Type (2015-2020)
Table 38. North America Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cystoid Macular Edema Market Share by Application (2015-2020)
Table 40. Europe Key Players Cystoid Macular Edema Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cystoid Macular Edema Market Share (2019-2020)
Table 42. Europe Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cystoid Macular Edema Market Share by Type (2015-2020)
Table 44. Europe Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cystoid Macular Edema Market Share by Application (2015-2020)
Table 46. China Key Players Cystoid Macular Edema Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cystoid Macular Edema Market Share (2019-2020)
Table 48. China Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 49. China Cystoid Macular Edema Market Share by Type (2015-2020)
Table 50. China Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 51. China Cystoid Macular Edema Market Share by Application (2015-2020)
Table 52. Japan Key Players Cystoid Macular Edema Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cystoid Macular Edema Market Share (2019-2020)
Table 54. Japan Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cystoid Macular Edema Market Share by Type (2015-2020)
Table 56. Japan Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cystoid Macular Edema Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cystoid Macular Edema Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cystoid Macular Edema Market Share (2019-2020)
Table 60. Southeast Asia Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cystoid Macular Edema Market Share by Type (2015-2020)
Table 62. Southeast Asia Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cystoid Macular Edema Market Share by Application (2015-2020)
Table 64. India Key Players Cystoid Macular Edema Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cystoid Macular Edema Market Share (2019-2020)
Table 66. India Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 67. India Cystoid Macular Edema Market Share by Type (2015-2020)
Table 68. India Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 69. India Cystoid Macular Edema Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cystoid Macular Edema Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cystoid Macular Edema Market Share (2019-2020)
Table 72. Central & South America Cystoid Macular Edema Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cystoid Macular Edema Market Share by Type (2015-2020)
Table 74. Central & South America Cystoid Macular Edema Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cystoid Macular Edema Market Share by Application (2015-2020)
Table 76. EMMES Company Details
Table 77. EMMES Business Overview
Table 78. EMMES Product
Table 79. EMMES Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 80. EMMES Recent Development
Table 81. Fovea Pharmaceuticals Company Details
Table 82. Fovea Pharmaceuticals Business Overview
Table 83. Fovea Pharmaceuticals Product
Table 84. Fovea Pharmaceuticals Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 85. Fovea Pharmaceuticals Recent Development
Table 86. Icon Bioscience Company Details
Table 87. Icon Bioscience Business Overview
Table 88. Icon Bioscience Product
Table 89. Icon Bioscience Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 90. Icon Bioscience Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Product
Table 94. Merck Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 95. Merck Recent Development
Table 96. Sanwa Kagaku Kenkyusho Company Details
Table 97. Sanwa Kagaku Kenkyusho Business Overview
Table 98. Sanwa Kagaku Kenkyusho Product
Table 99. Sanwa Kagaku Kenkyusho Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 100. Sanwa Kagaku Kenkyusho Recent Development
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Product
Table 104. Novartis Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 105. Novartis Recent Development
Table 106. Johns Hopkins University Company Details
Table 107. Johns Hopkins University Business Overview
Table 108. Johns Hopkins University Product
Table 109. Johns Hopkins University Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 110. Johns Hopkins University Recent Development
Table 111. Wake Forest University Business Overview
Table 112. Wake Forest University Product
Table 113. Wake Forest University Company Details
Table 114. Wake Forest University Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 115. Wake Forest University Recent Development
Table 116. Iladevi Cataract Company Details
Table 117. Iladevi Cataract Business Overview
Table 118. Iladevi Cataract Product
Table 119. Iladevi Cataract Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 120. Iladevi Cataract Recent Development
Table 121. IOL Research Center Company Details
Table 122. IOL Research Center Business Overview
Table 123. IOL Research Center Product
Table 124. IOL Research Center Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 125. IOL Research Center Recent Development
Table 126. Rabin Medical Center Company Details
Table 127. Rabin Medical Center Business Overview
Table 128. Rabin Medical Center Product
Table 129. Rabin Medical Center Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 130. Rabin Medical Center Recent Development
Table 131. Kyushu University Company Details
Table 132. Kyushu University Business Overview
Table 133. Kyushu University Product
Table 134. Kyushu University Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 135. Kyushu University Recent Development
Table 136. Wills Eye Institute Company Details
Table 137. Wills Eye Institute Business Overview
Table 138. Wills Eye Institute Product
Table 139. Wills Eye Institute Revenue in Cystoid Macular Edema Business (2015-2020) (Million US$)
Table 140. Wills Eye Institute Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystoid Macular Edema Market Share by Type: 2020 VS 2026
Figure 2. Non Steroidal Anti-Inflammatory Drugs Features
Figure 3. Anti- Vascular Endothelial Growth Factor (VEGF) Agents Features
Figure 4. Carbonic Anhydrase Inhibitors Features
Figure 5. Steroids Features
Figure 6. Global Cystoid Macular Edema Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Cystoid Macular Edema Report Years Considered
Figure 11. Global Cystoid Macular Edema Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cystoid Macular Edema Market Share by Regions: 2020 VS 2026
Figure 13. Global Cystoid Macular Edema Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cystoid Macular Edema Market Share by Players in 2019
Figure 16. Global Top Cystoid Macular Edema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystoid Macular Edema as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cystoid Macular Edema Revenue in 2019
Figure 18. North America Cystoid Macular Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cystoid Macular Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cystoid Macular Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cystoid Macular Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cystoid Macular Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cystoid Macular Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cystoid Macular Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
黄斑浮腫治療薬の世界市場（～2026年） Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cys…- 糖尿病性黄斑浮腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Diabetic Macular Edema Drug Market The global Diabetic Macular Edema Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetic Macular Edema Drug Scope and Market Size Diabetic …
- 糖尿病性黄斑浮腫治療の世界市場（～2026年） Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema. Increasing prevalence of diabetes in the prime factor driving …
- 黄斑変性症（AMD）の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. The North American region is the most lucrative market, ow…
- 黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…